NorthWest Biotherapeutics Inc (NWBO)

[Hopeforthefuture3]

Highwayman4, Thanks for the information that I find most discouraging for shareholders and more so for patients. If per the cited paper it takes median of 300 days to get data published, and nwbo intends no tld until publication then we may get tld say this August (2021) perhaps? Seems a far cry from when most of us watched Powers (early September 2020) in a luncheon presentation say September of 2020 for data to be released. Guess my coworker that passed from gbm never had a chance of any hope that dcvax-l might help. Same for my good friend's relative diagnosed last fall with gbm. Back in 2018 (or 2017) when they hit targeted # of events hoped might be approved and the standard by now.
That poor can has now been kicked so many times it now may resemble a smashed can.

Thankfully for my portfolio most of the companies I own stock in progress much quicker.
Just read the past year of press releases on another company -AVDL- and they like many others i have chose a much faster path. Imo AMRN was a great example of getting all the pieces together in a timely fashion tld in September and detailed presentation and NEJM paper a couple months later. Approval of course took well into the following year.
If nwbo really wants a published paper to go with tld could always make it a lot faster by using JTM again - not a high impact journal but certainly quick. Who knows...someday just no idea when that day will be. The poor patients hope they can get on a clinical trial
Good luck